Vector-borne diseases (VBDs) pose a significant public health concern in India, with increasing prevalence noted in recent years. This comprehensive review aims to provide healthcare professionals with an overview of this growing issue and discuss effective management strategies.
India's diverse climatic conditions and high population density facilitate the spread of VBDs. The most prevalent VBDs include Malaria, Dengue, and Chikungunya. The National Vector Borne Disease Control Programme (NVBDCP) reports an alarming rise in cases, highlighting the urgent need for effective control measures.
Several challenges hinder the management of VBDs in India. These include inadequate surveillance, limited access to healthcare facilities, and socio-economic factors. Furthermore, the widespread use of pesticides has led to vector resistance, complicating control efforts.
Effective management of VBDs requires a multi-pronged approach. This includes strengthening surveillance systems, ensuring timely diagnosis and treatment, and promoting community participation in vector control. Additionally, research into novel control methods, such as genetic manipulation of vectors, could offer new avenues for disease control.
Healthcare professionals play a pivotal role in managing VBDs. They are at the forefront of early detection and treatment, and their engagement in community education is crucial for disease prevention. Furthermore, they can contribute to policy-making and research, driving innovative solutions for VBD control.
The rising prevalence of VBDs in India necessitates a concerted effort from all stakeholders, including healthcare professionals. By understanding the current scenario and challenges, and by implementing effective management strategies, we can mitigate the impact of these diseases and safeguard public health.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation